Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%)
< Home < Back

Glenmark Life Sciences informs about newspaper advertisement

Date: 03-12-2022

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Life Sciences has informed that it enclosed copies of the newspaper advertisement informing about Postal Ballot Notice and e-Voting information published in Financial Express and Loksatta dated 3rd December, 2022.

The above information is a part of company’s filings submitted to BSE.